Scenario 2: Preservation of kidney function with arly switch to TAF in CHB patients living with comorbidities

23 Jun 2022


Q & A

1.Will you proactively identify and monitor the risk factors for renal function deterioration?

2.Do you agree TAF is a safe and effective CHB treatment with high potency?

3.Do you agree TAF is a simplified treatment? ​​​​​​​

4.Do you agree TAF can provide substantial recovery of the renal function after switching? ​​​​​​​

5.Do you agree early switching to TAF can help safeguard the renal health of CHB patients? Will you consider an early switch?

6.Will you start/switch TAF in patients with risk of deteriorating renal function?

Your answers will be used for educational purposes only. Personal information will not be disclosed to any third parties.

Related Articles